中华医学杂志（英文版）2013，Vol.126Issue(12)：2333-2336,4.DOI:10.3760/cma.j.issn.0366-6999.20121280
Serum HBV DNA level at week 12 is superior to viral response at week 24 in predicting long-term treatment outcome of telbivudine for chronic hepatitis B patients
Serum HBV DNA level at week 12 is superior to viral response at week 24 in predicting long-term treatment outcome of telbivudine for chronic hepatitis B patients
L(U) Wei 1YANG Hai-hong 2FAN Yun-ming 3LI Takming 3ZHANG Li-fan 1MUI Chongseong 3FAN Hong-wei1
作者信息
- 1. Department of Infectious Diseases, Peking Union Medical College Hospital, Beijing 100730, China
- 2. Department of Infectious Diseases, First Affiliated Hospital of Guangzhou Medical College, Guangzhou, Guangdong 510120, China
- 3. Department of Internal Medicine, Common Hospital Centre S.Januario, Macau, China
- 折叠
摘要
关键词
chronic hepatitis B/ telbivudine/ predictors/ long-term therapyKey words
chronic hepatitis B/ telbivudine/ predictors/ long-term therapy引用本文复制引用
L(U) Wei,YANG Hai-hong,FAN Yun-ming,LI Takming,ZHANG Li-fan,MUI Chongseong,FAN Hong-wei..Serum HBV DNA level at week 12 is superior to viral response at week 24 in predicting long-term treatment outcome of telbivudine for chronic hepatitis B patients[J].中华医学杂志（英文版）,2013,126(12):2333-2336,4.
